land-plant-high-yield

Research shows way to engineer high-yield crops

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: New research has uncovered a mechanism that regulates the reproduction of plants, providing a possible tool for engineering higher yielding crops. ... Read more

imugene-novel-linguet-drug-deluivery-technology-gets-japanese-patent

Japanese patent for Imugene drug delivery tech

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug delivery technology Linguet. Japanese application... Read more

dr-douglas-francis-clinical-network-services-new-senior-regulatory-toxicologist-for-biodesk-product-development-planning-and-regulatory-affairs-service

CNS hires former TGA toxicologist for BioDesk

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has appointed former Therapeutic Goods Administration... Read more

bionomics-to-raise-usd16

Bionomics to raise $16.4 mn for Alzheimer's R&D

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across drug pipeline, including BNC375, Bionomics'... Read more

mr-garth-tierney-the-new-executive-vice-president-asia-pacific-inc-research

Garth Tierney is executive VP of INC CRO

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible for driving the strategic development and... Read more

alchemia-enrols-patients-for-cancer-trial

Alchemia enrolls patients for cancer trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead product, HA-Irinotecan, for the treatment of... Read more

prima-biomed-starts-patient-recruitment-for-phase-ii-iii-ovarian-cancer-vaccine-trial

Prima recruits patients for cancer vaccine trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine... Read more

signostics-ultrasound-device

Signostics unveils new ultrasound device

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Signostics, an Adelaide-based medical devices company, has unveiled its new ultrasound device Signos RT. The device is Signostics' second generation portable... Read more

qrxpharma-resubmits-moxduo-nda-to-us-fda

QRxPharma resubmits Moxduo NDA to US FDA

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: QRxPharma announced that the company resubmitted its Moxduo New Drug Application (NDA) to the US FDA. As disclosed on January 16, 2013, at its last meeting... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X